期刊
BIOLOGICAL RESEARCH
卷 45, 期 3, 页码 269-277出版社
SOC BIOLGIA CHILE
DOI: 10.4067/S0716-97602012000300008
关键词
Mesenchymal stem cells; autoimmune diseases; cellular therapy
类别
资金
- Universidad de los Andes [MED-004-7, MED 002/09]
- lnnova Chile Corfo [205-4350]
Mesenchymal stem cells (MSCs) are now known to display not only stem cell multipotency, but also robust antiinflammatory and regenerative properties. After widespread in-vitro and in-vivo preclinical testing, autologous and allogeneic MSCs have been applied in a range of immune mediated conditions, including graft versus host disease, Crohn's disease, multiple sclerosis, refractory systemic lupus erythematosus and systemic sclerosis. Current data suggests that MSCs may not only replace diseased tissues, but also exert several trophic, regenerative and antiinflarnmatory effects. While the clinical outcome in case reports and phase trials seems occasionally striking, these limited results point to the need to perform controlled multicenter trials. Future advances from stem cell science can be expected to pinpoint significant MSC subpopulations and/or stem cell markers for improved regenerative or immunoregulatory properties.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据